Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.87
Delayed Data
As of Oct 20
 +0.01 / +0.26%
Today’s Change
2.67
Today|||52-Week Range
5.10
+44.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues52.0K40.4K78.4K9.4K
 
 
 
 
 
Cost of Goods Sold45.2K35.8K45.2K26.6K
 
 
 
 
 
Depreciation And Amortization710.001.3K288.00288.00
 
 
 
 
 
 
Operating ExpensesGross Income6.1K3.3K32.9K-17.5K
 
 
 
 
 
General Expenses3.1M2.8M2.8M2.6M
 
 
 
 
 
Research And Development2.0M1.6M1.7M1.6M
 
 
 
 
 
Total Operating Expenses3.1M2.8M2.8M2.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.0M-2.8M-2.8M-2.6M
 
 
 
 
 
Interest Expense On Debt78.3K49.5K51.5K108.2K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.1M-2.8M-2.8M-2.7M
 
 
 
 
 
Net Income-3.1M-2.8M-2.8M-2.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS46.9M49.1M49.7M51.5M
 
 
 
 
 
Shares To Calculate EPS Diluted46.9M49.1M49.7M51.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.05-$0.06-$0.05
 
 
 
 
 
EPS Diluted-$0.07-$0.06-$0.06-$0.05